Latest CLSD reports update at 2024-03-12: 2023 ∙ 2022 ∙ 2021
  1. Home
  2. Stock quotes
  3. Clearside Biomedical
  4. Financial Statements
Clearside Biomedical logo
Clearside Biomedical CLSD
$ 1.35 6.3%
mail-toReport an Error

Clearside Biomedical Financial Statements 2011-2024 | CLSD

Annual Financial Statements Clearside Biomedical

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 101 M 62 M 93.3 M 154 M 137 M 36 M 161 M 95.1 M - - - - -

Shares

 61.8 M 60.2 M 58.5 M 46.5 M 38.2 M 30.7 M 25.3 M 13.1 M - - - - -

Historical Prices

 1.64 1.03 1.59 3.31 2.24 1.45 6.46 7.85 - - - - -

Net Income

 -32.5 M -32.9 M 376 K -18.2 M -30.8 M -82.8 M -59 M -25.9 M -17.6 M -10.2 M -7.25 M - -

Revenue

 8.23 M 1.33 M 29.6 M 7.89 M 2.17 M 30 K 345 K 520 K - - - - -

Cost of Revenue

 355 K 204 K - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - -

Operating Income

 -24.8 M -30.3 M -627 K -17.9 M -30.3 M -82.9 M -58.4 M -25.2 M -17.3 M -9.82 M - - -

Interest Expense

 - - - - - - - - - - - - -

EBITDA

 -24.8 M -30.1 M -449 K -17.8 M -30.1 M -82.8 M -58.2 M -25.1 M -17.2 M -9.78 M -7.22 M - -

Operating Expenses

 33.1 M 31.6 M 30.2 M 25.8 M 32.5 M 83 M 58.8 M 25.7 M - - - - -

General and Administrative Expenses

 11.9 M 11.8 M 11.7 M 10.8 M 16.8 M 14.7 M 9.7 M 6.26 M - - - - -

All numbers in USD currency

Quarterly Income Statement Clearside Biomedical

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 62 M 61.7 M 61.2 M 60.6 M 60.2 M 60.2 M 60.1 M 59.7 M 59.5 M 57.7 M 57 M 51.9 M 47 M 45.2 M 44.8 M 44.4 M 38.4 M 37.6 M 34.1 M 32.1 M 32 M 32 M 26.8 M 25.4 M 25.3 M 25.3 M 25.3 M 24.6 M 20.5 M 8.24 M 2.66 M 2.66 M 2.65 M 2.22 M - - - - - - - - - - - - - - - - -

Net Income

 -9.27 M -9.11 M -9.28 M - -7.83 M -7.81 M -7.64 M - -4.89 M -6.1 M -7.35 M - -2.43 M -5.75 M -2.91 M -3.1 M -6.54 M -5.73 M -15.4 M -21.6 M -23.9 M -20.7 M -16.6 M -16.5 M -18.3 M -13.8 M -10.4 M -9.69 M -5.64 M -5.1 M -5.45 M -5.17 M -3.48 M -5.33 M -3.76 M - - - - - - - - - - - - - - - -

Revenue

 859 K 1.02 M 4 K - 266 K 384 K 347 K - 3.07 M 780 K 34 K - 3.43 M 354 K 4.1 M - 141 K 45 K 45 K - - - - - 155 K 130 K - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

 142 K 213 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

 -7.05 M -7.27 M -7.6 M - -6.72 M -7.84 M -7.65 M - -4.89 M -6.1 M -8.35 M - -2.43 M -5.56 M -2.84 M - -6.37 M -5.62 M -15.3 M - -24 M -20.9 M -16.5 M - -18.2 M -13.6 M -10.3 M - -5.31 M -5.18 M -5.36 M - -3.37 M -5.17 M - - - - - - - - - - - - - - - - -

Interest Expense

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

 - - -7.59 M - -6.6 M -7.75 M -7.6 M - -4.76 M -6.01 M -8.3 M - -2.3 M -5.47 M -2.79 M - -6.21 M -5.51 M -15.3 M - -23.8 M -20.8 M -16.4 M - -18.1 M -13.6 M -10.2 M - -5.26 M -5.15 M -5.34 M - -3.33 M -5.14 M - - - - - - - - - - - - - - - - -

Operating Expenses

 7.91 M 8.29 M 7.61 M - 6.99 M 8.22 M 7.99 M - 7.96 M 6.88 M 8.38 M - 5.86 M 5.91 M 6.93 M 4.96 M 6.51 M 5.66 M 15.4 M 21.7 M 24 M 20.9 M 16.5 M 16.4 M 18.3 M 13.8 M 10.3 M 9.36 M 5.31 M 5.18 M 5.86 M 5.02 M 3.37 M 5.17 M 3.76 M - - - - - - - - - - - - - - - -

General and Administrative Expenses

 2.64 M 3.13 M 3.16 M - 2.35 M 2.79 M 3.46 M - 2.82 M 2.82 M 2.89 M - 2.37 M 2.61 M 3.12 M - 3.78 M 5 M 4.38 M - 3.87 M 3.56 M 3.07 M - 2.3 M 2.29 M 2.67 M - 1.63 M 970 K 1.27 M - 1.06 M 3.02 M - - - - - - - - - - - - - - - - -

All numbers in USD currency